Overview

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Status:
Recruiting
Trial end date:
2027-03-01
Target enrollment:
Participant gender:
Summary
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
Phase:
N/A
Details
Lead Sponsor:
Edwards Lifesciences